Rodolphe Obeid
Chief Operating Officer chez Intelgenx Corp.
Profil
Rodolphe Obeid is currently the Vice President-Operations at Intelgenx Corp.
He was previously the Chief Operating Officer at IntelGenx Technologies Corp.
from 2019 to 2022.
Dr. Obeid holds a doctorate degree from the University of Montréal and a graduate degree from the University of Strasbourg.
Postes actifs de Rodolphe Obeid
| Sociétés | Poste | Début |
|---|---|---|
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Chief Operating Officer | 05/02/2019 |
Anciens postes connus de Rodolphe Obeid
| Sociétés | Poste | Fin |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Chief Operating Officer | 01/12/2022 |
Formation de Rodolphe Obeid
| University of Montréal | Doctorate Degree |
| University of Strasbourg | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
